BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog 2017;13:e1006654. [PMID: 29267402 DOI: 10.1371/journal.ppat.1006654] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Katsinelos T, Doulberis M, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J. Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection Involvement. Curr Mol Med 2019;20:3-12. [PMID: 31530263 DOI: 10.2174/1566524019666190917125917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17:25. [PMID: 31952509 DOI: 10.1186/s12974-020-1705-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 35.5] [Reference Citation Analysis]
3 Guo L, Xu J, Du Y, Wu W, Nie W, Zhang D, Luo Y, Lu H, Lei M, Xiao S, Liu J. Effects of gut microbiota and probiotics on Alzheimer’s disease. Translational Neuroscience 2021;12:573-80. [DOI: 10.1515/tnsci-2020-0203] [Reference Citation Analysis]
4 Zhang Y, Liu Y, Tang Y, Zhang D, He H, Wu J, Zheng J. Antimicrobial α-defensins as multi-target inhibitors against amyloid formation and microbial infection. Chem Sci 2021;12:9124-39. [PMID: 34276942 DOI: 10.1039/d1sc01133b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fleury V, Zekeridou A, Lazarevic V, Gaïa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR. Oral Dysbiosis and Inflammation in Parkinson's Disease. J Parkinsons Dis 2021;11:619-31. [PMID: 33646178 DOI: 10.3233/JPD-202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer's Disease. J Neurogastroenterol Motil 2019;25:48-60. [PMID: 30646475 DOI: 10.5056/jnm18087] [Cited by in Crossref: 212] [Cited by in F6Publishing: 184] [Article Influence: 70.7] [Reference Citation Analysis]
7 Kortel M, Mansuriya BD, Vargas Santana N, Altintas Z. Graphene Quantum Dots as Flourishing Nanomaterials for Bio-Imaging, Therapy Development, and Micro-Supercapacitors. Micromachines (Basel) 2020;11:E866. [PMID: 32962061 DOI: 10.3390/mi11090866] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
9 Maitre Y, Mahalli R, Micheneau P, Delpierre A, Amador G, Denis F. Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer's Disease: A Systematic Review. Int J Environ Res Public Health 2021;18:11157. [PMID: 34769677 DOI: 10.3390/ijerph182111157] [Reference Citation Analysis]
10 Hewel C, Kaiser J, Wierczeiko A, Linke J, Reinhardt C, Endres K, Gerber S. Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota. Front Neurosci 2019;13:113. [PMID: 30890906 DOI: 10.3389/fnins.2019.00113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
11 Seo DO, Holtzman DM. Gut Microbiota: From the Forgotten Organ to a Potential Key Player in the Pathology of Alzheimer's Disease. J Gerontol A Biol Sci Med Sci 2020;75:1232-41. [PMID: 31738402 DOI: 10.1093/gerona/glz262] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 23.0] [Reference Citation Analysis]
12 Zhao Y, Lukiw WJ. Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer's Disease. Front Neurol 2018;9:145. [PMID: 29615954 DOI: 10.3389/fneur.2018.00145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
13 Vuuren MJV, Nell TA, Carr JA, Kell DB, Pretorius E. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease. Biomolecules 2020;11:E30. [PMID: 33383805 DOI: 10.3390/biom11010030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ticinesi A, Nouvenne A, Tana C, Prati B, Meschi T. Gut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging. Adv Exp Med Biol 2019;1178:129-54. [PMID: 31493226 DOI: 10.1007/978-3-030-25650-0_8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Liang S, Wu X, Jin F. Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis. Front Integr Neurosci 2018;12:33. [PMID: 30271330 DOI: 10.3389/fnint.2018.00033] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 18.0] [Reference Citation Analysis]
16 Borsom EM, Lee K, Cope EK. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease. Brain Sci 2020;10:E814. [PMID: 33153085 DOI: 10.3390/brainsci10110814] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Milošević M, Arsić A, Cvetković Z, Vučić V. Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition. Front Nutr 2021;8:688086. [PMID: 34422879 DOI: 10.3389/fnut.2021.688086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tonomura S, Ihara M, Friedland RP. Microbiota in cerebrovascular disease: A key player and future therapeutic target. J Cereb Blood Flow Metab 2020;40:1368-80. [PMID: 32312168 DOI: 10.1177/0271678X20918031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
19 Lee JG, Cho HJ, Jeong YM, Lee JS. Genetic Approaches Using Zebrafish to Study the Microbiota-Gut-Brain Axis in Neurological Disorders. Cells 2021;10:566. [PMID: 33807650 DOI: 10.3390/cells10030566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 D'Argenio V, Sarnataro D. Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases. Int J Mol Sci 2019;20:E4704. [PMID: 31547531 DOI: 10.3390/ijms20194704] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
21 Ticinesi A, Tana C, Nouvenne A. The intestinal microbiome and its relevance for functionality in older persons. Curr Opin Clin Nutr Metab Care 2019;22:4-12. [PMID: 30489399 DOI: 10.1097/MCO.0000000000000521] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 10.7] [Reference Citation Analysis]
22 Wang XQ, Li H, Li XN, Yuan CH, Zhao H. Gut-Brain Axis: Possible Role of Gut Microbiota in Perioperative Neurocognitive Disorders. Front Aging Neurosci 2021;13:745774. [PMID: 35002672 DOI: 10.3389/fnagi.2021.745774] [Reference Citation Analysis]
23 Sharma C, Kim SR. Linking Oxidative Stress and Proteinopathy in Alzheimer's Disease. Antioxidants (Basel) 2021;10:1231. [PMID: 34439479 DOI: 10.3390/antiox10081231] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Van Gerven N, Van der Verren SE, Reiter DM, Remaut H. The Role of Functional Amyloids in Bacterial Virulence. J Mol Biol 2018;430:3657-84. [PMID: 30009771 DOI: 10.1016/j.jmb.2018.07.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 15.0] [Reference Citation Analysis]
25 Qian XH, Song XX, Liu XL, Chen SD, Tang HD. Inflammatory pathways in Alzheimer's disease mediated by gut microbiota. Ageing Res Rev 2021;68:101317. [PMID: 33711509 DOI: 10.1016/j.arr.2021.101317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ. Gut microbiota and pro/prebiotics in Alzheimer's disease. Aging (Albany NY) 2020;12:5539-50. [PMID: 32191919 DOI: 10.18632/aging.102930] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
27 Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, Thron T, Needham BD, Horvath I, Debelius JW, Janssen S, Knight R, Wittung-Stafshede P, Gradinaru V, Chapman M, Mazmanian SK. A gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice. Elife 2020;9:e53111. [PMID: 32043464 DOI: 10.7554/eLife.53111] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 35.0] [Reference Citation Analysis]
28 Cheng W, Ho Y, Chang RC. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101620] [Reference Citation Analysis]
29 Lv W, Cui Y, Xue G, Wang Z, Niu L, Chai X, Wang Y. Potential value and chemical characterization of gut microbiota derived nitrogen containing metabolites in feces from Periplaneta americana (L.) at different growth stages. Sci Rep 2021;11:21191. [PMID: 34707100 DOI: 10.1038/s41598-021-00182-0] [Reference Citation Analysis]
30 Szulc N, Gąsior-Głogowska M, Wojciechowski JW, Szefczyk M, Żak AM, Burdukiewicz M, Kotulska M. Variability of Amyloid Propensity in Imperfect Repeats of CsgA Protein of Salmonella enterica and Escherichia coli. Int J Mol Sci 2021;22:5127. [PMID: 34066237 DOI: 10.3390/ijms22105127] [Reference Citation Analysis]
31 Sharma P, Agrawal A. Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade. Neurosurg Rev 2021. [PMID: 33904013 DOI: 10.1007/s10143-021-01516-2] [Reference Citation Analysis]
32 Javed I, Zhang Z, Adamcik J, Andrikopoulos N, Li Y, Otzen DE, Lin S, Mezzenga R, Davis TP, Ding F, Ke PC. Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC. Adv Sci (Weinh) 2020;7:2001299. [PMID: 32999841 DOI: 10.1002/advs.202001299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
33 Isaiah S, Loots DT, Solomons R, van der Kuip M, Tutu Van Furth AM, Mason S. Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis. Front Neurosci 2020;14:296. [PMID: 32372900 DOI: 10.3389/fnins.2020.00296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Chu CQ, Yu LL, Qi GY, Mi YS, Wu WQ, Lee YK, Zhai QX, Tian FW, Chen W. Can dietary patterns prevent cognitive impairment and reduce Alzheimer's disease risk: exploring the underlying mechanisms of effects. Neurosci Biobehav Rev 2022;:104556. [PMID: 35122783 DOI: 10.1016/j.neubiorev.2022.104556] [Reference Citation Analysis]
35 Osorio C, Kanukuntla T, Diaz E, Jafri N, Cummings M, Sfera A. The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling. Front Aging Neurosci 2019;11:143. [PMID: 31297054 DOI: 10.3389/fnagi.2019.00143] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
36 Wittung-Stafshede P. Gut power: Modulation of human amyloid formation by amyloidogenic proteins in the gastrointestinal tract. Curr Opin Struct Biol 2021;72:33-8. [PMID: 34450484 DOI: 10.1016/j.sbi.2021.07.009] [Reference Citation Analysis]
37 Perni M, Mannini B, Xu CK, Kumita JR, Dobson CM, Chiti F, Vendruscolo M. Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans. Sci Rep 2021;11:14391. [PMID: 34257326 DOI: 10.1038/s41598-021-93527-8] [Reference Citation Analysis]
38 Vendrell-Fernández S, Lozano-Picazo P, Cuadros-Sánchez P, Tejero-Ojeda MM, Giraldo R. Conversion of the OmpF Porin into a Device to Gather Amyloids on the E. coli Outer Membrane. ACS Synth Biol 2021. [PMID: 34852197 DOI: 10.1021/acssynbio.1c00347] [Reference Citation Analysis]
39 Bellezza I, Peirce MJ, Minelli A. Cyclic Peptides in Neurological Disorders: The Case of Cyclo(His-Pro). Quorum Sensing. Elsevier; 2019. pp. 257-86. [DOI: 10.1016/b978-0-12-814905-8.00010-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease. CNS Drugs 2020;34:673-95. [PMID: 32458360 DOI: 10.1007/s40263-020-00737-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
41 Sharma VK, Singh TG, Garg N, Dhiman S, Gupta S, Rahman MH, Najda A, Walasek-Janusz M, Kamel M, Albadrani GM, Akhtar MF, Saleem A, Altyar AE, Abdel-Daim MM. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress? Biomolecules 2021;11:678. [PMID: 33946488 DOI: 10.3390/biom11050678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
42 Haran JP, McCormick BA. Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease. Gastroenterology 2021;160:507-23. [PMID: 33307030 DOI: 10.1053/j.gastro.2020.09.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Lee EY, Srinivasan Y, de Anda J, Nicastro LK, Tükel Ç, Wong GCL. Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation. Front Immunol 2020;11:1629. [PMID: 32849553 DOI: 10.3389/fimmu.2020.01629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
44 Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease. FEBS J 2021;288:2836-55. [PMID: 32969566 DOI: 10.1111/febs.15571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
45 Needham BD, Kaddurah-daouk R, Mazmanian SK. Gut microbial molecules in behavioural and neurodegenerative conditions. Nat Rev Neurosci 2020;21:717-31. [DOI: 10.1038/s41583-020-00381-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
46 Ke PC, Zhou R, Serpell LC, Riek R, Knowles TPJ, Lashuel HA, Gazit E, Hamley IW, Davis TP, Fändrich M, Otzen DE, Chapman MR, Dobson CM, Eisenberg DS, Mezzenga R. Half a century of amyloids: past, present and future. Chem Soc Rev 2020;49:5473-509. [PMID: 32632432 DOI: 10.1039/c9cs00199a] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 39.5] [Reference Citation Analysis]
47 Shabbir U, Arshad MS, Sameen A, Oh DH. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients 2021;13:690. [PMID: 33669988 DOI: 10.3390/nu13020690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
48 Boeri L, Perottoni S, Izzo L, Giordano C, Albani D. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling. Adv Healthc Mater 2021;10:e2002043. [PMID: 33661580 DOI: 10.1002/adhm.202002043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sampson T. The impact of indigenous microbes on Parkinson's disease. Neurobiology of Disease 2020;135:104426. [DOI: 10.1016/j.nbd.2019.03.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
50 Bostanciklioğlu M. The role of gut microbiota in pathogenesis of Alzheimer's disease. J Appl Microbiol 2019;127:954-67. [PMID: 30920075 DOI: 10.1111/jam.14264] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
51 Tetz G, Pinho M, Pritzkow S, Mendez N, Soto C, Tetz V. Bacterial DNA promotes Tau aggregation. Sci Rep 2020;10:2369. [PMID: 32047247 DOI: 10.1038/s41598-020-59364-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
52 Ticinesi A, Tana C, Nouvenne A, Prati B, Lauretani F, Meschi T. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clin Interv Aging 2018;13:1497-511. [PMID: 30214170 DOI: 10.2147/CIA.S139163] [Cited by in Crossref: 67] [Cited by in F6Publishing: 45] [Article Influence: 16.8] [Reference Citation Analysis]
53 Kitani-Morii F, Friedland RP, Yoshida H, Mizuno T. Drosophila as a Model for Microbiota Studies of Neurodegeneration. J Alzheimers Dis 2021;84:479-90. [PMID: 34569965 DOI: 10.3233/JAD-215031] [Reference Citation Analysis]
54 Farooqui T, Farooqui AA. Potential Therapeutic Impacts of Curcumin for Improving Memory Impairment. Curcumin for Neurological and Psychiatric Disorders. Elsevier; 2019. pp. 257-73. [DOI: 10.1016/b978-0-12-815461-8.00014-1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Lekchand Dasriya V, Samtiya M, Dhewa T, Puniya M, Kumar S, Ranveer S, Chaudhary V, Vij S, Behare P, Singh N, Aluko RE, Puniya AK. Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation. J Food Biochem 2021;:e14043. [PMID: 34927261 DOI: 10.1111/jfbc.14043] [Reference Citation Analysis]
56 Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr. The Gut and Parkinson's Disease-A Bidirectional Pathway. Front Neurol 2019;10:574. [PMID: 31214110 DOI: 10.3389/fneur.2019.00574] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 17.0] [Reference Citation Analysis]
57 Ticinesi A, Mancabelli L, Carnevali L, Nouvenne A, Meschi T, Del Rio D, Ventura M, Sgoifo A, Angelino D. Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers. J Alzheimers Dis 2022. [PMID: 35147544 DOI: 10.3233/JAD-215493] [Reference Citation Analysis]
58 Kurlawala Z, Shadowen PH, McMillan JD, Beverly LJ, Friedland RP. Progression of Nonmotor Symptoms in Parkinson's Disease by Sex and Motor Laterality. Parkinsons Dis 2021;2021:8898887. [PMID: 33868631 DOI: 10.1155/2021/8898887] [Reference Citation Analysis]
59 Westwell-Roper C, Verchere CB. Modulation of Innate Immunity by Amyloidogenic Peptides. Trends Immunol 2019;40:762-80. [PMID: 31320280 DOI: 10.1016/j.it.2019.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Cerovic M, Forloni G, Balducci C. Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease? Front Aging Neurosci 2019;11:284. [PMID: 31680937 DOI: 10.3389/fnagi.2019.00284] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
61 Khambhati K, Patel J, Saxena V, A P, Jain N. Gene Regulation of Biofilm-Associated Functional Amyloids. Pathogens 2021;10:490. [PMID: 33921583 DOI: 10.3390/pathogens10040490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Tetz G, Tetz V. Bacterial Extracellular DNA Promotes β-Amyloid Aggregation. Microorganisms 2021;9:1301. [PMID: 34203755 DOI: 10.3390/microorganisms9061301] [Reference Citation Analysis]
63 Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease. J Neuroinflammation 2018;15:276. [PMID: 30249283 DOI: 10.1186/s12974-018-1313-3] [Cited by in Crossref: 136] [Cited by in F6Publishing: 121] [Article Influence: 34.0] [Reference Citation Analysis]
64 Jie Z, Liang S, Ding Q, Li F, Sun X, Lin Y, Chen P, Cai K, Wang X, Zhang T, Zhou H, Lu H, Xiao L, Yang H, Wang J, Hou Y, Kristiansen K, Jia H, Xu X. Dairy consumption and physical fitness tests associated with fecal microbiome in a Chinese cohort. Medicine in Microecology 2021;9:100038. [DOI: 10.1016/j.medmic.2021.100038] [Reference Citation Analysis]
65 Mulak A. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease. J Alzheimers Dis 2021;84:461-77. [PMID: 34569953 DOI: 10.3233/JAD-210608] [Reference Citation Analysis]
66 Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 2018;21:1332-40. [PMID: 30250260 DOI: 10.1038/s41593-018-0235-9] [Cited by in Crossref: 292] [Cited by in F6Publishing: 252] [Article Influence: 73.0] [Reference Citation Analysis]
67 Mammeri NE, Hierrezuelo J, Tolchard J, Cámara‐almirón J, Caro‐astorga J, Álvarez‐mena A, Dutour A, Berbon M, Shenoy J, Morvan E, Grélard A, Kauffmann B, Lecomte S, Vicente A, Habenstein B, Romero D, Loquet A. Molecular architecture of bacterial amyloids in Bacillus biofilms. FASEB j 2019;33:12146-63. [DOI: 10.1096/fj.201900831r] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
68 Jeyakumar T, Beauchemin N, Gros P. Impact of the Microbiome on the Human Genome. Trends Parasitol 2019;35:809-21. [PMID: 31451407 DOI: 10.1016/j.pt.2019.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Shin HE, Kwak SE, Lee JH, Zhang D, Bae JH, Song W. Exercise, the Gut Microbiome, and Frailty. Ann Geriatr Med Res 2019;23:105-14. [PMID: 32743298 DOI: 10.4235/agmr.19.0014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
70 Megur A, Baltriukienė D, Bukelskienė V, Burokas A. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame? Nutrients 2020;13:E37. [PMID: 33374235 DOI: 10.3390/nu13010037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
71 Tetz G, Brown SM, Hao Y, Tetz V. Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages. Sci Rep 2019;9:9685. [PMID: 31273267 DOI: 10.1038/s41598-019-46087-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
72 Liu M, Zhong P. Modulating the Gut Microbiota as a Therapeutic Intervention for Alzheimer’s Disease. Indian J Microbiol. [DOI: 10.1007/s12088-022-01025-w] [Reference Citation Analysis]
73 Gupta A, Mahalakshmi R. Single-residue physicochemical characteristics kinetically partition membrane protein self-assembly and aggregation. J Biol Chem 2020;295:1181-94. [PMID: 31844019 DOI: 10.1074/jbc.RA119.011342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Angoorani P, Ejtahed HS, Siadat SD, Sharifi F, Larijani B. Is There Any Link between Cognitive Impairment and Gut Microbiota? A Systematic Review. Gerontology 2022;:1-13. [PMID: 35263739 DOI: 10.1159/000522381] [Reference Citation Analysis]
75 Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases? Life (Basel) 2021;11:698. [PMID: 34357070 DOI: 10.3390/life11070698] [Reference Citation Analysis]
76 Rahimi Araghi L, Dee DR. Cross-Species and Cross-Polymorph Seeding of Lysozyme Amyloid Reveals a Dominant Polymorph. Front Mol Biosci 2020;7:206. [PMID: 32923456 DOI: 10.3389/fmolb.2020.00206] [Reference Citation Analysis]
77 Friedland RP, McMillan JD, Kurlawala Z. What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders? Int J Mol Sci 2020;21:E1652. [PMID: 32121263 DOI: 10.3390/ijms21051652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
78 Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacol Ther 2021;:107988. [PMID: 34536490 DOI: 10.1016/j.pharmthera.2021.107988] [Reference Citation Analysis]
79 Welcome MO. Current Perspectives and Mechanisms of Relationship between Intestinal Microbiota Dysfunction and Dementia: A Review. Dement Geriatr Cogn Dis Extra 2018;8:360-81. [PMID: 30483303 DOI: 10.1159/000492491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
80 Hill AE, Wade-Martins R, Burnet PWJ. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Front Neurosci 2021;15:708587. [PMID: 34512244 DOI: 10.3389/fnins.2021.708587] [Reference Citation Analysis]
81 Wang H, Zhang S, Yang F, Xin R, Wang S, Cui D, Sun Y. The gut microbiota confers protection in the CNS against neurodegeneration induced by manganism. Biomed Pharmacother 2020;127:110150. [PMID: 32330797 DOI: 10.1016/j.biopha.2020.110150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
82 Romanenko M, Kholin V, Koliada A, Vaiserman A. Nutrition, Gut Microbiota, and Alzheimer's Disease. Front Psychiatry 2021;12:712673. [PMID: 34421687 DOI: 10.3389/fpsyt.2021.712673] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Więckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev 2021;70:101397. [PMID: 34214643 DOI: 10.1016/j.arr.2021.101397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhu WJ, Liu Y, Cao YN, Peng LX, Yan ZY, Zhao G. Insights into Health-Promoting Effects of Plant MicroRNAs: A Review. J Agric Food Chem 2021;69:14372-86. [PMID: 34813309 DOI: 10.1021/acs.jafc.1c04737] [Reference Citation Analysis]
85 Timmermans JP. Need for more holistic therapeutic and management strategies to understand the causal or correlative link of the Aβ amyloid pathway with Alzheimer's disease for a more efficiënt treatment. Peptides 2018;102:75-7. [PMID: 29524561 DOI: 10.1016/j.peptides.2018.03.002] [Reference Citation Analysis]
86 Ionescu RF, Enache RM, Cretoiu SM, Cretoiu D. The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases. Front Cardiovasc Med 2022;9:856901. [DOI: 10.3389/fcvm.2022.856901] [Reference Citation Analysis]
87 Escobar YH, O’piela D, Wold LE, Mackos AR. Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-215290] [Reference Citation Analysis]
88 Beg AZ, Farhat N, Khan AU. Designing multi-epitope vaccine candidates against functional amyloids in Pseudomonas aeruginosa through immunoinformatic and structural bioinformatics approach. Infect Genet Evol 2021;93:104982. [PMID: 34186254 DOI: 10.1016/j.meegid.2021.104982] [Reference Citation Analysis]
89 La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, Iorio CD, Rossi P. The Gut-Brain Axis in Alzheimer's Disease and Omega-3. A Critical Overview of Clinical Trials. Nutrients 2018;10:E1267. [PMID: 30205543 DOI: 10.3390/nu10091267] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
90 Narengaowa, Kong W, Lan F, Awan UF, Qing H, Ni J. The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease. Front Cell Neurosci 2021;15:633735. [PMID: 33935651 DOI: 10.3389/fncel.2021.633735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Kosolapova AO, Antonets KS, Belousov MV, Nizhnikov AA. Biological Functions of Prokaryotic Amyloids in Interspecies Interactions: Facts and Assumptions. Int J Mol Sci 2020;21:E7240. [PMID: 33008049 DOI: 10.3390/ijms21197240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
92 Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci 2021;264:118627. [PMID: 33169684 DOI: 10.1016/j.lfs.2020.118627] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
93 Dumitrescu L, Popescu-Olaru I, Cozma L, Tulbă D, Hinescu ME, Ceafalan LC, Gherghiceanu M, Popescu BO. Oxidative Stress and the Microbiota-Gut-Brain Axis. Oxid Med Cell Longev 2018;2018:2406594. [PMID: 30622664 DOI: 10.1155/2018/2406594] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
94 Pluta R, Januszewski S, Czuczwar SJ. The Role of Gut Microbiota in an Ischemic Stroke. Int J Mol Sci 2021;22:E915. [PMID: 33477609 DOI: 10.3390/ijms22020915] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M. Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications. Transl Neurodegener 2021;10:49. [PMID: 34876226 DOI: 10.1186/s40035-021-00273-y] [Reference Citation Analysis]
96 Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine. ACS Nano 2020;14:14391-416. [DOI: 10.1021/acsnano.0c07258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
97 Murray ER, Kemp M, Nguyen TT. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Arch Clin Neuropsychol 2022:acac008. [PMID: 35202456 DOI: 10.1093/arclin/acac008] [Reference Citation Analysis]
98 Glowacki RWP, Martens EC. In sickness and health: Effects of gut microbial metabolites on human physiology. PLoS Pathog 2020;16:e1008370. [PMID: 32271839 DOI: 10.1371/journal.ppat.1008370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
99 Shandilya S, Kumar S, Kumar Jha N, Kumar Kesari K, Ruokolainen J. Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection. Journal of Advanced Research 2022;38:223-44. [DOI: 10.1016/j.jare.2021.09.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Welcome MO. Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways. Neuromolecular Med 2019;21:205-26. [PMID: 31115795 DOI: 10.1007/s12017-019-08547-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
101 Li M, Chen WD, Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol Med 2020;26:101. [PMID: 33160314 DOI: 10.1186/s10020-020-00234-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
102 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
103 Giovannini MG, Lana D, Traini C, Vannucchi MG. The Microbiota-Gut-Brain Axis and Alzheimer Disease. From Dysbiosis to Neurodegeneration: Focus on the Central Nervous System Glial Cells. J Clin Med 2021;10:2358. [PMID: 34072107 DOI: 10.3390/jcm10112358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
104 Miller AL, Pasternak JA, Medeiros NJ, Nicastro LK, Tursi SA, Hansen EG, Krochak R, Sokaribo AS, MacKenzie KD, Palmer MB, Herman DJ, Watson NL, Zhang Y, Wilson HL, Wilson RP, White AP, Tükel Ç. In vivo synthesis of bacterial amyloid curli contributes to joint inflammation during S. Typhimurium infection. PLoS Pathog 2020;16:e1008591. [PMID: 32645118 DOI: 10.1371/journal.ppat.1008591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
105 Łuc M, Misiak B, Pawłowski M, Stańczykiewicz B, Zabłocka A, Szcześniak D, Pałęga A, Rymaszewska J. Gut microbiota in dementia. Critical review of novel findings and their potential application. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110039. [PMID: 32687964 DOI: 10.1016/j.pnpbp.2020.110039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
106 Wang F, Fei M, Hu W, Wang X, Liu S, Zeng Y, Zhang J, Lv Y, Niu J, Meng X, Cai P, Li Y, Gang B, You Y, Lv Y, Ji Y. Prevalence of Constipation in Elderly and Its Association With Dementia and Mild Cognitive Impairment: A Cross-Sectional Study. Front Neurosci 2022;15:821654. [DOI: 10.3389/fnins.2021.821654] [Reference Citation Analysis]
107 Wang H, Yang F, Xin R, Cui D, He J, Zhang S, Sun Y. The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome. Biomed Pharmacother 2020;129:110449. [PMID: 32768944 DOI: 10.1016/j.biopha.2020.110449] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
108 Białecka-Dębek A, Granda D, Szmidt MK, Zielińska D. Gut Microbiota, Probiotic Interventions, and Cognitive Function in the Elderly: A Review of Current Knowledge. Nutrients 2021;13:2514. [PMID: 34444674 DOI: 10.3390/nu13082514] [Reference Citation Analysis]
109 Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems Biology Approaches to Understand the Host-Microbiome Interactions in Neurodegenerative Diseases. Front Neurosci 2020;14:716. [PMID: 32733199 DOI: 10.3389/fnins.2020.00716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
110 Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Neuropsychiatr Dis Treat 2021;17:1311-39. [PMID: 33976546 DOI: 10.2147/NDT.S264910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Beg AZ, Khan AU. Motifs and interface amino acid-mediated regulation of amyloid biogenesis in microbes to humans: potential targets for intervention. Biophys Rev 2020;12:1249-56. [PMID: 32930961 DOI: 10.1007/s12551-020-00759-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Adams B, Nunes JM, Page MJ, Roberts T, Carr J, Nell TA, Kell DB, Pretorius E. Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens. Front Aging Neurosci 2019;11:210. [PMID: 31507404 DOI: 10.3389/fnagi.2019.00210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
113 Lester-Zer N, Ghrayeb M, Chai L. Nanomechanical properties of steric zipper globular structures. Proc Natl Acad Sci U S A 2019;116:22478-84. [PMID: 31636220 DOI: 10.1073/pnas.1908782116] [Reference Citation Analysis]
114 Svob Strac D, Konjevod M, Sagud M, Nikolac Perkovic M, Nedic Erjavec G, Vuic B, Simic G, Vukic V, Mimica N, Pivac N. Personalizing the Care and Treatment of Alzheimer's Disease: An Overview. Pharmgenomics Pers Med 2021;14:631-53. [PMID: 34093032 DOI: 10.2147/PGPM.S284615] [Reference Citation Analysis]
115 Ternák G, Kuti D, Kovács KJ. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics. Med Hypotheses 2020;137:109564. [PMID: 31954994 DOI: 10.1016/j.mehy.2020.109564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
116 Kumar MR, Azizi NF, Yeap SK, Abdullah JO, Khalid M, Omar AR, Osman MA, Leow ATC, Mortadza SAS, Alitheen NB. Clinical and Preclinical Studies of Fermented Foods and Their Effects on Alzheimer’s Disease. Antioxidants 2022;11:883. [DOI: 10.3390/antiox11050883] [Reference Citation Analysis]
117 Forero-rodríguez LJ, Josephs-spaulding J, Flor S, Pinzón A, Kaleta C. Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach. Antioxidants 2022;11:71. [DOI: 10.3390/antiox11010071] [Reference Citation Analysis]
118 Checa-Ros A, Jeréz-Calero A, Molina-Carballo A, Campoy C, Muñoz-Hoyos A. Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients 2021;13:249. [PMID: 33467150 DOI: 10.3390/nu13010249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
119 Laurence M, Benito-León J, Calon F. Malassezia and Parkinson's Disease. Front Neurol 2019;10:758. [PMID: 31396143 DOI: 10.3389/fneur.2019.00758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
120 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
121 Wysocki K. Genomics of aging: Decreased immune defenses. J Am Assoc Nurse Pract 2021;33:100-1. [PMID: 33560750 DOI: 10.1097/JXX.0000000000000579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Giorgi FS, Saccaro LF, Galgani A, Busceti CL, Biagioni F, Frati A, Fornai F. The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease. Brain Research Bulletin 2019;153:47-58. [DOI: 10.1016/j.brainresbull.2019.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
123 Perov S, Lidor O, Salinas N, Golan N, Tayeb-Fligelman E, Deshmukh M, Willbold D, Landau M. Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents. PLoS Pathog 2019;15:e1007978. [PMID: 31469892 DOI: 10.1371/journal.ppat.1007978] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
124 Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, McCormick BA. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio 2019;10:e00632-19. [PMID: 31064831 DOI: 10.1128/mBio.00632-19] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 28.3] [Reference Citation Analysis]
125 Lerner A. The intestinal luminal sources of α-synuclein: a gastroenterologist perspective. Nutr Rev 2021:nuab024. [PMID: 33942062 DOI: 10.1093/nutrit/nuab024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, van der Flier WM, de Vries HE. Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease. Front Immunol 2021;12:683068. [PMID: 34135909 DOI: 10.3389/fimmu.2021.683068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
127 Honarpisheh P, Reynolds CR, Blasco Conesa MP, Moruno Manchon JF, Putluri N, Bhattacharjee MB, Urayama A, McCullough LD, Ganesh BP. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice. Int J Mol Sci 2020;21:E1711. [PMID: 32138161 DOI: 10.3390/ijms21051711] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
128 Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis 2020;136:104714. [PMID: 31846737 DOI: 10.1016/j.nbd.2019.104714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
129 Revilla-García A, Fernández C, Moreno-Del Álamo M, de Los Ríos V, Vorberg IM, Giraldo R. Intercellular Transmission of a Synthetic Bacterial Cytotoxic Prion-Like Protein in Mammalian Cells. mBio 2020;11:e02937-19. [PMID: 32291306 DOI: 10.1128/mBio.02937-19] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 Jamerlan A, An SSA, Hulme J. Advances in amyloid beta oligomer detection applications in Alzheimer's disease. TrAC Trends in Analytical Chemistry 2020;129:115919. [DOI: 10.1016/j.trac.2020.115919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
131 Tran SM, Mohajeri MH. The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease. Nutrients 2021;13:732. [PMID: 33669008 DOI: 10.3390/nu13030732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
132 Kowalski K, Mulak A. Small intestinal bacterial overgrowth in Alzheimer's disease. J Neural Transm (Vienna) 2021. [PMID: 34797427 DOI: 10.1007/s00702-021-02440-x] [Reference Citation Analysis]
133 Conte C, Sichetti M, Traina G. Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells. Applied Sciences 2020;10:1828. [DOI: 10.3390/app10051828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
134 Doroszkiewicz J, Groblewska M, Mroczko B. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System. Int J Mol Sci 2021;22:10028. [PMID: 34576191 DOI: 10.3390/ijms221810028] [Reference Citation Analysis]
135 Olsen I, Kell DB, Pretorius E. Is Porphyromonas gingivalis involved in Parkinson's disease? Eur J Clin Microbiol Infect Dis 2020;39:2013-8. [PMID: 32564247 DOI: 10.1007/s10096-020-03944-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
136 Ke PC, Pilkington EH, Sun Y, Javed I, Kakinen A, Peng G, Ding F, Davis TP. Mitigation of Amyloidosis with Nanomaterials. Adv Mater 2020;32:e1901690. [PMID: 31183916 DOI: 10.1002/adma.201901690] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
137 Álvarez-Mena A, Cámara-Almirón J, de Vicente A, Romero D. Multifunctional Amyloids in the Biology of Gram-Positive Bacteria. Microorganisms 2020;8:E2020. [PMID: 33348645 DOI: 10.3390/microorganisms8122020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
139 Binvignat O, Olloquequi J. Excitotoxicity as a Target Against Neurodegenerative Processes. Curr Pharm Des 2020;26:1251-62. [PMID: 31931694 DOI: 10.2174/1381612826666200113162641] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]